SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: david cohen who wrote (150)4/2/1997 6:20:00 PM
From: Claud B   of 7041
 
Hi David,

If the results of their Phase III trials are as expected,
the company plans to file an NDA with the FDA in June or July.
Figure 6 months to a year for approval. (conservative.)

See the Barron's story about a month ago. Estimated market could
be $1 billion. (Not all for Zonagen.) But let's say they get
10-20% of the market. The rest is mathematics.

Also, they expect to be selling Vasomax in either the
3rd or 4th quarter of THIS year in Mexico.Anyone planning a trip to
Acapulco??

Hope this helps.

ClaudB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News